文献速递脑血管病神经重症与神经感染

急性卒中患者急性肾病与静脉造影剂给药的相关性:基于人群研究

Association Between Acute Kidney Disease and Intravenous Dye Administration in Patients With Acute Stroke: A Population-Based Study.
PubMed 文献 · Stroke · 2017-03-03

该研究基于2010年大辛辛那提/北肯塔基地区2299例急性缺血性卒中或脑出血患者,评估入院时未识别肾病患病率及住院期间急性肾损伤发生率,并分析其与静脉造影剂给药的关系。

要点

  • 卒中患者中22%存在未识别的基线肾病。
  • 基线肾病患者急性肾损伤发生率为2%,无肾病者为1%。
  • 静脉造影剂给药与新发或恶化肾病无关联。

核心结论

  • 静脉造影剂给药与卒中患者新发或恶化肾病无关联。

研究设计与样本

  • 基于人群的回顾性研究,纳入2010年大辛辛那提/北肯塔基地区所有因急性缺血性卒中或脑出血就诊于急诊的成年居民,共2299例(89%缺血性卒中,11%脑出血),平均年龄69岁(SD 15),22%黑人,54%女性。

主要发现

  • 37%患者基线存在肾病,其中22%(516/2299)为未识别肾病。
  • 基线肾病患者中2%(15/853)住院期间发生急性肾损伤。
  • 造影剂给药与新发或恶化肾病无关联。

临床怎么用

  • 卒中患者急诊评估时应注意识别未诊断的基线肾病。
  • 静脉造影剂用于卒中影像评估时,严重肾并发症风险较低。

局限性

  • 原文未明确报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Computed tomographic angiography and conventional angiography provide timely vascular anatomic information in patients with stroke. However, iodinated contrast dye may cause acute kidney injury (AKI). Within a large, biracial population, we examined in-hospital incidence of new or worsening kidney disease in patients with stroke and its association with administration of intravenous dye. METHODS: All adult residents of the Greater Cincinnati/Northern Kentucky region with acute ischemic stroke or intracerebral hemorrhage who presented to an emergency department in 2010 were included. Prevalence of unsuspected kidney disease at the time of emergency department presentation and the incidence of AKI after admission in 2 groups of patients-those who did and those who did not receive intravenous dye-were determined. RESULTS: In 2010, 2299 patients met inclusion criteria (89% ischemic stroke and 11% intracerebral hemorrhage); mean age 69 years (SD 15), 22% black, and 54% women. Among these patients, 37% had kidney disease at baseline, including 22% (516/2299) in whom this was unsuspected. Two percent (2%; 15/853) of patients with baseline kidney disease developed AKI during the hospital stay. Of those with no baseline kidney disease, 1% (14/14 467) developed AKI. There was no association between dye administration and new or worsening kidney disease. CONCLUSIONS: Although 22% of patients in the Greater Cincinnati/Northern Kentucky stroke population had unsuspected kidney disease, the incidence of new or worsening kidney disease was low, and AKI was not associated with dye administration. These findings confirm single-center reports that the risk of severe renal complications after contrast dye is small.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Demel SL, Grossman AW, Khoury JC, et al. Association Between Acute Kidney Disease and Intravenous Dye Administration in Patients With Acute Stroke: A Population-Based Study. Stroke. 2017. PMID: 28258258. doi:10.1161/STROKEAHA.116.014603

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。